Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

ICAM-1

Alternative Names: icam-1
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Subcutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: National Cancer Institute (NCI)
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
EDIPE

N/A

Not yet recruiting

Pre-Eclampsia|Hypertension|Pregnancy Outcomes

2026-05-01

ChiCTR1900027080

N/A

Recruiting

Hypertension|GNE Myopathy|Heart Failure, Systolic|Heart Failure, Chronic|Diabetes Complications|Dyspnea|Coronary Disease|Ventricular Dysfunction, Left|Heart Failure, Diastolic

2022-12-31

Recent News Events

Date

Type

Title

05/15/2024

PubMed

 Whole genome sequencing based analysis of inflammation biomarkers in the Trans-Omics for Precision Medicine (TOPMed) consortium.

05/15/2024

PubMed

 Effects of Nox4 upregulation on PECAM-1 expression in a mouse model of diabetic retinopathy.

05/02/2024

PubMed

 Rapid Assessment of Biomarkers on Single Extracellular Vesicles Using 'Catch and Display' on Ultrathin Nanoporous Silicon Nitride Membranes.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions